Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease

NCT02061202 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Mometasone Furoate
DRUG: Placebo

Sponsor

Jeffrey Glassberg

Collaborators

[object Object]